US FDA Grants Accelerated Approval for Iovance’s Skin Cancer Cell Therapy

US FDA Grants Accelerated Approval for Iovance’s Skin Cancer Cell Therapy

Iovance Biotherapeutics announced on Friday that the U.S. health regulator has granted accelerated approval for its cell therapy aimed at…